(Q46857146)

25 December 2017

title

Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats (English)

1 reference

25 December 2017

author name string

Rocco Barazzoni

1

1 reference

25 December 2017

Michela Zanetti

2

1 reference

25 December 2017

Maria Rosa Cattin

3

1 reference

25 December 2017

Luca Visintin

4

1 reference

25 December 2017

Pierandrea Vinci

5

1 reference

25 December 2017

Luigi Cattin

6

1 reference

25 December 2017

Marco Stebel

7

1 reference

25 December 2017

Gianfranco Guarnieri

8

1 reference

25 December 2017

publication date

1 November 2007

1 reference

25 December 2017

published in

Obesity

1 reference

25 December 2017

volume

15

1 reference

25 December 2017

page(s)

2614-2623

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

A role for ghrelin in the central regulation of feeding

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin causes hyperphagia and obesity in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin induces adiposity in rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Plasma ghrelin response following a period of acute overfeeding in normal weight men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Circulating ghrelin levels are decreased in human obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Skeletal muscle mitochondrial protein metabolism and function in ageing and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Direct effect of ghrelin on leptin production by cultured rat white adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

From receptor to transporter: insulin signalling to glucose transport.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Moderate caloric restriction, but not physiological hyperleptinemia per se, enhances mitochondrial oxidative capacity in rat liver and skeletal muscle--tissue-specific impact on tissue triglyceride content and AKT activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Interorgan signaling between adipose tissue metabolism and skeletal muscle uncoupling protein homologs: is there a role for circulating free fatty acids?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Glucose utilization and insulin action in adult rats submitted to prolonged food restriction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Cerebrospinal fluid ghrelin is negatively associated with body mass index.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin action in the brain controls adipocyte metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Fasting in healthy individuals and adaption to undernutrition during chronic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Dose-dependent inhibition by ghrelin of insulin secretion in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Leptin downregulates ghrelin levels in streptozotocin-induced diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.313

31 March 2020

Identifiers

DOI

10.1038/OBY.2007.313

1 reference

25 December 2017

PubMed ID

18070752

1 reference

25 December 2017